The Asia-Pacific allergy Immunotherapies Market was valued at US$ 365.47 million in 2019 and is projected to reach US$ 871.08 million by 2027; it is expected to grow at a CAGR of 11.5% during the forecast period.
The strong presence of leading companies in emerging Asian markets and investments for enhancement of SLIT, standardization of dosage, and evaluation of long-term outcomes can be attributed to the market growth.Allergy immunotherapy is a medical treatment useful for environmental allergies, allergies to insect bites, and asthma. The Allergy Immunotherapy market in the Asia Pacific region is expected to exhibit the highest growth rate due to the increased incidence of allergy people in developing Asian countries like China & India. In Asia Pacific countries, around 20-30% of the total population possesses more than one allergy. Forming an excellent regulatory scenario for the sale of drugs through online pharmacies will boost allergy immunotherapy business growth and development. The growing unmet needs of novel targeted drugs, which are used to treat the allergic conditions, will create growth opportunities for the market players. Many companies are investing in research and development to develop targeted drugs for various allergic disorders. To increase their share in the market, companies are introducing more and more allergen immunotherapy tablets (AITs) in potential markets.
The Covid-19 pandemic has harmed allergy immunotherapies market size, with small and medium scale companies struggling to sustain their businesses in the near-term future. Industry leaders are now focusing on creating new business practices to deal with crises like covid-19 pandemic.
Asia Pacific Allergy Immunotherapies Market Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION
Asia Pacific Allergy Immunotherapies Market – By Treatment
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
Asia Pacific Allergy Immunotherapies Market – By Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
Asia Pacific Allergy Immunotherapies Market – By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Asia Pacific Allergy Immunotherapies Market – By Country
- Japan
- India
- Australia
- South Korea
- China
Company Profiles
- HAL Allergy B.V.
- ALK Abello A/S
- Stallergenes Greer
- Anergis
- Circassia
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment and Sublingual Immunotherapy , Allergy Type, Distribution Channel, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Allergy Immunotherapies Market – By Treatment
1.3.2 Asia Pacific Allergy Immunotherapies Market – By Allergy Type
1.3.3 Asia Pacific Allergy Immunotherapies Market – By Distribution Channel
1.3.4 Asia Pacific Allergy Immunotherapies Market – By Geography
2. Asia Pacific Allergy Immunotherapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Allergy Immunotherapies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia-Pacific – PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Allergy immunotherapies Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Allergic Disorders
5.1.2 Technological Advancements in Sublingual Dosage Formulations
5.2 Key Market Restraint
5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
5.2.2 Regulatory Variations Across Regions
5.3 Key Market Opportunities
5.3.1 Expansion of Pharmacy across Globe
5.4 Future Trends
5.4.1 Increasing Research and Development for Drugs
5.5 Impact Analysis
6. Allergy Immunotherapies Market – Asia Pacific Analysis
6.1.1 Asia-Pacific: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
7. Asia Pacific Allergy Immunotherapies Market Analysis– by Treatment
7.1 Overview
7.2 Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
7.3 Subcutaneous Immunotherapy (SCIT)
7.3.1 Overview
7.4 Sublingual Immunotherapy (SLIT)
7.4.1 Overview
7.4.2 Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
8. Allergy Immunotherapies Market Analysis– by Allergy Type
8.1 Overview
8.2 Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
8.3 Allergic Rhinitis
8.3.1 Overview
8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Asthma
8.4.1 Overview
8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Food Allergy
8.5.1 Overview
8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.6 Venom Allergy
8.6.1 Overview
8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.7 Other Allergies
8.7.1 Overview
8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)
9. Allergy Immunotherapies Market Analysis– by Distribution Channel
9.1 Overview
9.2 Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)
10. Allergy Immunotherapies Market Analysis And Forecasts To 2027 – Geographical Analysis
10.1 Asia-Pacific: Allergy Immunotherapies Market
10.1.1 Overview
10.1.2 Asia-Pacific: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Asia-Pacific Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.4 Asia-Pacific Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.1.7 China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 China Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 China Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 China Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Japan Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Japan Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Japan Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 India Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 India Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 India Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.10 South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 South Korea Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.10.3 South Korea Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.10.4 South Korea Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.11 Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Australia Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Australia Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Australia Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific Allergy Immunotherapies Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 ALK-Abelló A/S
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Stallergenes Greer
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 HAL Allergy B.V.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Johnson and Johnson Services, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Anergis
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 DBV Technologies
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Allergy Therapeutics
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 Glossary of Terms
LIST OF TABLES
Table 1. Asia-Pacific Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 2. Asia-Pacific Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 3. Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 4. China Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 5. China Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 6. China Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 8. Japan Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Japan Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. India Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 11. India Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. India Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. South Korea Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 14. South Korea Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 15. South Korea Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 16. Australia Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 17. Australia Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Australia Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 19. Glossary of Terms, Allergy Immunotherapies Market
LIST OF FIGURES
Figure 1. Allergy Immunotherapies Market Segmentation
Figure 2. Asia Pacific Allergy Immunotherapies Market Overview
Figure 3. Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market
Figure 4. Asia-Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Global Allergy Immunotherapies Market- Leading Country Markets (US$ Million)
Figure 7. Asia-Pacific PEST Analysis
Figure 8. Allergy immunotherapies Market Impact Analysis of Driver and Restraints
Figure 9. Asia-Pacific Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)
Figure 10. Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)
Figure 11. Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 12. Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 13. Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)
Figure 14. Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
Figure 15. Asthma Market Revenue and Forecasts to 2027 (US$ Million)
Figure 16. Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 17. Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 18. Others Market Revenue and Forecasts to 2027 (US$ Million)
Figure 19. Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)
Figure 20. Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 21. Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)
Figure 22. Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 23. Asia-Pacific: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)
Figure 24. Asia-Pacific Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)
Figure 25. Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 26. China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of COVID-19 Pandemic on allergy immunotherapies market in Asia Pacific Countries
- HAL Allergy B.V.
- ALK Abello A/S
- Stallergenes Greer
- Anergis
- Circassia
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Allergy Immunotherapies Market
Sep 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Sep 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Sep 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)